55 related articles for article (PubMed ID: 1506705)
1. [A clinical experience of V-A bypass using a new antithrombotic coating material].
Kawahito K; Ino T; Ide H; Adachi H; Mizuhara A; Yamaguchi A
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jul; 40(7):1110-5. PubMed ID: 1506705
[TBL] [Abstract][Full Text] [Related]
2. [A clinical and experimental study of the antithrombotic percutaneous cardiopulmonary support using the new antithrombotic coating material].
Kawahito K
Nihon Kyobu Geka Gakkai Zasshi; 1993 Sep; 41(9):1467-77. PubMed ID: 8409600
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of a fluorine-acryl-stylene-urethane-silicone antithrombogenic coating material copolymer for intravascular stents.
Matsuhashi T; Miyachi H; Ishibashi T; Sakamoto K; Yamadera A
Acad Radiol; 1996 Jul; 3(7):581-8. PubMed ID: 8796720
[TBL] [Abstract][Full Text] [Related]
4. [In vivo evaluation of the new antithrombogenic reservoir-catheter coated with polymer blend copolymer].
Matsumoto S; Yamada Y; Kiyosue H; Dono S; Mori H; Imagawa M; Nomura Y; Toyoda H; Shimada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):238-43. PubMed ID: 9164111
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
7. [An experimental study of a newly developed silicone coated membrane oxygenator].
Iida M
Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):700-10. PubMed ID: 9170861
[TBL] [Abstract][Full Text] [Related]
8. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
Zimmermann N; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting.
Mirow N; Minami K; Kleikamp G; Tenderich G; Puhlmann T; Körfer R
Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470
[TBL] [Abstract][Full Text] [Related]
13. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
17. Beating-heart coronary artery bypass grafting using a miniaturized extracorporeal circulation system.
Reber D; Fritz M; Tossios P; Buchwald D; Lindstaedt M; Klak K; Marks P; Laczkovics A
Heart Surg Forum; 2008; 11(5):E276-80. PubMed ID: 18948240
[TBL] [Abstract][Full Text] [Related]
18. Parallel flow arteriovenous shunt for the ex vivo evaluation of heparinized materials.
Ip WF; Zingg W; Sefton MV
J Biomed Mater Res; 1985 Feb; 19(2):161-78. PubMed ID: 4077878
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antithrombogenicity of a new microdomain structured copolymer.
Kawahito K; Tasai K; Murata S; Yamaguchi A; Mizuhara A; Adachi H; Ino T
Artif Organs; 1995 Aug; 19(8):857-63. PubMed ID: 8573009
[TBL] [Abstract][Full Text] [Related]
20. Heparinized styrene-butadiene-styrene elastomers.
Goosen MF; Sefton MV
J Biomed Mater Res; 1979 May; 13(3):347-64. PubMed ID: 438224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
